Antiepileptic Drugs: A Case Report in a Pregnancy With a Neural Tube Defect

Pediatric Neurology

Volumn 34, Issue 4, 2006, Pages 323-324

  Candito, Mirande ^a   Guéant, Jean Louis ^b   Naimi, Mourad ^a   Bongain, Alain ^c   Van Obberghen, Emmanuel ^a  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LAMOTRIGINE; PYRIDOXINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CASE REPORT; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FERTILIZATION IN VITRO; FOLATE METABOLISM; GENOTYPE; HUMAN; MULTIPLE PREGNANCY; MUTATION; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; VITAMIN SUPPLEMENTATION;

ADULT; ANTICONVULSANTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, MULTIPLE; TRIAZINES; TRIPLETS; VITAMIN B COMPLEX;

EID: 33646085335     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2005.08.023     Document Type: Article

References (5)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects. Results of the Medical Research Council Vitamin Study. Lancet 338 (1991) 131-137
2. Yerby M.S. Clinical care of pregnant women with epilepsy. Neural tube defects and folic acid supplementation. Epilepsia 44 Suppl. 3 (2003) 33-40
3. Stables J.P., Bialer M., Johannessen S., et al. Progress report on new antiepileptic drugs. A summary of the second Eilat Conference. Epilepsy Res 2 (1995) 235-246
4. Kirke P.N., Mills J.L., Molloy A.M., et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects. Case-control study. BMJ 328 (2004) 1535-1536
5. Honein M., Paulozzi L., Mathews T., and Wong I. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285 (2001) 2981-2986